166 related articles for article (PubMed ID: 1534841)
1. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor.
Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI
J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841
[TBL] [Abstract][Full Text] [Related]
2. [Activity and localization of neutral metalloendopeptidase (EC 3.4.24.11) (NEP), the degradative enzyme for atrial natriuretic peptide (ANP), in rat kidney].
Kanazawa M; Yasujima M; Kohzuki M; Abe K
Nihon Jinzo Gakkai Shi; 1994 Jul; 36(7):791-9. PubMed ID: 8072216
[TBL] [Abstract][Full Text] [Related]
3. Rat vascular tissue contains a neutral endopeptidase capable of degrading atrial natriuretic peptide.
Tamburini PP; Koehn JA; Gilligan JP; Charles D; Palmesino RA; Sharif R; McMartin C; Erion MD; Miller MJ
J Pharmacol Exp Ther; 1989 Dec; 251(3):956-61. PubMed ID: 2532252
[TBL] [Abstract][Full Text] [Related]
4. Distribution and inhibition of neutral metalloendopeptidase (NEP) (EC 3.4.24.11), the major degradative enzyme for atrial natriuretic peptide, in the rat kidney.
Kanazawa M; Johnston CI
Clin Exp Pharmacol Physiol; 1991 Jun; 18(6):449-53. PubMed ID: 1833101
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of kidney neutral endopeptidase after administration of the neutral endopeptidase inhibitor candoxatril: quantitation by autoradiography.
Yoshida K; Kanazawa M; Casley DJ; Katopothis A; Johnston CI
J Cardiovasc Pharmacol; 1998 Nov; 32(5):702-8. PubMed ID: 9821842
[TBL] [Abstract][Full Text] [Related]
6. Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.
Walther T; Stepan H; Pankow K; Becker M; Schultheiss HP; Siems WE
Biol Chem; 2004 Feb; 385(2):179-84. PubMed ID: 15101560
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495.
Burrell LM; Farina N; Risvanis J; Woollard D; Casely D; Johnston CI
Clin Sci (Lond); 1997 Jul; 93(1):43-50. PubMed ID: 9279202
[TBL] [Abstract][Full Text] [Related]
8. Specific receptor binding of atrial natriuretic peptide to rat renal cortex.
Ogura T; Mitsui T; Ogawa N; Ota Z
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):353-60. PubMed ID: 2932778
[TBL] [Abstract][Full Text] [Related]
9. [Identification and characterization of neutral endopeptidase in endothelial cells of arterial or venous origin].
Llorens-Cortes C; Huang H; Gasc JM; Corvol P
C R Seances Soc Biol Fil; 1992; 186(6):599-611. PubMed ID: 1339590
[TBL] [Abstract][Full Text] [Related]
10. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure.
Wegner M; Hirth-Dietrich C; Stasch JP
Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244
[TBL] [Abstract][Full Text] [Related]
11. SCH 39370, a neutral metalloendopeptidase inhibitor, potentiates biological responses to atrial natriuretic factor and lowers blood pressure in desoxycorticosterone acetate-sodium hypertensive rats.
Sybertz EJ; Chiu PJ; Vemulapalli S; Pitts B; Foster CJ; Watkins RW; Barnett A; Haslanger MF
J Pharmacol Exp Ther; 1989 Aug; 250(2):624-31. PubMed ID: 2547941
[TBL] [Abstract][Full Text] [Related]
12. A 94-kDa protein, identified as neutral endopeptidase-24.11, can inactivate atrial natriuretic peptide in the vascular endothelium.
Soleilhac JM; Lucas E; Beaumont A; Turcaud S; Michel JB; Ficheux D; Fournié-Zaluski MC; Roques BP
Mol Pharmacol; 1992 Apr; 41(4):609-14. PubMed ID: 1533267
[TBL] [Abstract][Full Text] [Related]
13. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit.
Marleau S; Nguyen TT; Du Souich P; Bellemare M; De Lean A; Ong H
Drug Metab Dispos; 1991; 19(1):194-9. PubMed ID: 1673398
[TBL] [Abstract][Full Text] [Related]
14. In vitro macro- and micro-autoradiographic localization of atrial natriuretic peptide in the rat kidney.
Yamamoto I; Ogura T; Ota Z
Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):185-98. PubMed ID: 2955492
[TBL] [Abstract][Full Text] [Related]
15. Successive action of meprin A and neprilysin catabolizes B-type natriuretic peptide.
Pankow K; Wang Y; Gembardt F; Krause E; Sun X; Krause G; Schultheiss HP; Siems WE; Walther T
Circ Res; 2007 Oct; 101(9):875-82. PubMed ID: 17823376
[TBL] [Abstract][Full Text] [Related]
16. Renal responses to atrial natriuretic peptide are preserved in bilateral ureteral obstruction and augmented by neutral endopeptidase inhibition.
Ryndin I; Gulmi FA; Chou SY; Mooppan UM; Kim H
J Urol; 2005 Feb; 173(2):651-6. PubMed ID: 15643282
[TBL] [Abstract][Full Text] [Related]
17. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor.
Tikkanen I; Helin K; Tikkanen T; Sybertz EJ; Vemulapalli S; Sariola H; Näveri H; Fyhrquist F
J Pharmacol Exp Ther; 1990 Aug; 254(2):641-5. PubMed ID: 2143536
[TBL] [Abstract][Full Text] [Related]
18. Ortho-substituted benzofused macrocyclic lactams as zinc metalloprotease inhibitors.
Ksander GM; de Jesus R; Yuan A; Ghai RD; Trapani A; McMartin C; Bohacek R
J Med Chem; 1997 Feb; 40(4):495-505. PubMed ID: 9046340
[TBL] [Abstract][Full Text] [Related]
19. Intrarenal effects of ecadotril during acute volume expansion in dogs with congestive heart failure.
Solter P; Sisson D; Thomas W; Goetze L
J Pharmacol Exp Ther; 2000 Jun; 293(3):989-95. PubMed ID: 10869402
[TBL] [Abstract][Full Text] [Related]
20. Interaction of mammalian neprilysin with binding protein and calnexin in Schizosaccharomyces pombe.
Beaulieu H; Elagöz A; Crine P; Rokeach LA
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):813-9. PubMed ID: 10359668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
